Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...
Winnie Byanyima, from UNAIDS: ‘Lenacapavir is more effective than condoms or PrEP in prevention’
The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...
Hopefulness comes from a faith and belief that things have a way of evolving toward the good. The moral arc of the universe ...
Researchers assessed whether switching to protease inhibitor-based antiretroviral therapy mitigates or reverses weight gain in patients with HIV infection.
GlobalData on MSN1d
Gilead and MSD to advance once-weekly HIV treatment to Phase IIIThe companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...
Gilead and Merck & Co. have guided their once-weekly HIV combination therapy past another milestone, linking the cocktail to ...
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...
Clarence Peeples is part of a small club in the HIV community. He is using his experiences to help fight the virus among ...
Proof-of-Concept Study to Find Functional Cure for HIV July 24, 2024 — Researchers conducted a breakthrough proof-of-concept study that found an HIV-like virus particle that could cease the need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback